NCT05454371View on ClinicalTrials.gov

Investigation of Urinary Biomarkers for the Detection of Prostate Cancer

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Prostate CancerUrineLiquid Biopsy
Interventions
DEVICE

Colli-Pee UAS devices

Colli-Pee UAS device variants will be evaluated during this study

Trial Locations (1)

2650

Universitair ziekenhuis Antwerpen, Edegem

Sponsors

Lead Sponsor

Novosanis NV
All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

lead

Novosanis NV

INDUSTRY

NCT05454371 - Investigation of Urinary Biomarkers for the Detection of Prostate Cancer | Biotech Hunter | Biotech Hunter